These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes. Li Chew C; Lunardi A; Gulluni F; Ruan DT; Chen M; Salmena L; Nishino M; Papa A; Ng C; Fung J; Clohessy JG; Sasaki J; Sasaki T; Bronson RT; Hirsch E; Pandolfi PP Cancer Discov; 2015 Jul; 5(7):740-51. PubMed ID: 25883022 [TBL] [Abstract][Full Text] [Related]
3. Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers. Fedele CG; Ooms LM; Ho M; Vieusseux J; O'Toole SA; Millar EK; Lopez-Knowles E; Sriratana A; Gurung R; Baglietto L; Giles GG; Bailey CG; Rasko JE; Shields BJ; Price JT; Majerus PW; Sutherland RL; Tiganis T; McLean CA; Mitchell CA Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22231-6. PubMed ID: 21127264 [TBL] [Abstract][Full Text] [Related]
5. Phosphoinositide 3-kinase and INPP4B in human breast cancer. Bertucci MC; Mitchell CA Ann N Y Acad Sci; 2013 Mar; 1280():1-5. PubMed ID: 23551093 [TBL] [Abstract][Full Text] [Related]
6. INPP4B Is a Tumor Suppressor in the Context of PTEN Deficiency. Vo TT; Fruman DA Cancer Discov; 2015 Jul; 5(7):697-700. PubMed ID: 26152921 [TBL] [Abstract][Full Text] [Related]
7. INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway. Chen Y; Sun Z; Qi M; Wang X; Zhang W; Chen C; Liu J; Zhao W J Cell Mol Med; 2018 May; 22(5):2935-2943. PubMed ID: 29516642 [TBL] [Abstract][Full Text] [Related]
8. INPP4B overexpression suppresses migration, invasion and angiogenesis of human prostate cancer cells. Chen H; Li H; Chen Q Clin Exp Pharmacol Physiol; 2017 Jun; 44(6):700-708. PubMed ID: 28261855 [TBL] [Abstract][Full Text] [Related]
9. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. Gewinner C; Wang ZC; Richardson A; Teruya-Feldstein J; Etemadmoghadam D; Bowtell D; Barretina J; Lin WM; Rameh L; Salmena L; Pandolfi PP; Cantley LC Cancer Cell; 2009 Aug; 16(2):115-25. PubMed ID: 19647222 [TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor β regulates AKT activity through up-regulation of INPP4B and inhibits migration of prostate cancer cell line PC-3. Chaurasiya S; Wu W; Strom AM; Warner M; Gustafsson JÅ Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26347-26355. PubMed ID: 33020300 [TBL] [Abstract][Full Text] [Related]
11. INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer. Rodgers SJ; Ooms LM; Oorschot VMJ; Schittenhelm RB; Nguyen EV; Hamila SA; Rynkiewicz N; Gurung R; Eramo MJ; Sriratana A; Fedele CG; Caramia F; Loi S; Kerr G; Abud HE; Ramm G; Papa A; Ellisdon AM; Daly RJ; McLean CA; Mitchell CA Nat Commun; 2021 May; 12(1):3140. PubMed ID: 34035258 [TBL] [Abstract][Full Text] [Related]
12. A tumor suppressor function for the lipid phosphatase INPP4B in melanocytic neoplasms. Perez-Lorenzo R; Gill KZ; Shen CH; Zhao FX; Zheng B; Schulze HJ; Silvers DN; Brunner G; Horst BA J Invest Dermatol; 2014 May; 134(5):1359-1368. PubMed ID: 24288008 [TBL] [Abstract][Full Text] [Related]
13. Signaling pathways of D3-phosphoinositide-binding kinases in T cells and their regulation by PTEN. Seminario MC; Wange RL Semin Immunol; 2002 Feb; 14(1):27-36. PubMed ID: 11884228 [TBL] [Abstract][Full Text] [Related]
14. PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. Paez J; Sellers WR Cancer Treat Res; 2003; 115():145-67. PubMed ID: 12613196 [No Abstract] [Full Text] [Related]
15. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway. Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867 [TBL] [Abstract][Full Text] [Related]
16. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line. Lee S; Choi EJ; Jin C; Kim DH Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433 [TBL] [Abstract][Full Text] [Related]
17. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells. Asano T; Yao Y; Zhu J; Li D; Abbruzzese JL; Reddy SA Oncogene; 2004 Nov; 23(53):8571-80. PubMed ID: 15467756 [TBL] [Abstract][Full Text] [Related]